Feature
A tale of two specialities: how two researchers combined to solve a problem
A clinician and non-clinical researcher have combined forces to investigate the cause of several patients presenting with the same condition.
Feature
Is singing good for your respiratory health?
Researchers are trying to understand the secret to the success of singing groups set up to benefit patients with respiratory conditions like COPD.
Feature
Lung Disease: a meeting of minds - first joint event with Weill-Cornell and NHLI
The National Heart & Lung Institute was delighted to host the first joint meeting with Weill-Cornell at the Guy Scadding Building earlier this month.
New light shed on improving treatment for COPD exacerbations
Research by Professor Wedzicha of the National Heart and Lung Institute (NHLI) finds better combination therapy for treating COPD exacerbations.
Can a Centre of Excellence open the door for mesothelioma treatment?
A new National Mesothelioma Centre is to be launched by the National Heart and Lung Institute.
Gene therapy for cystic fibrosis shows encouraging trial results
A therapy that replaces the faulty gene responsible for cystic fibrosis in patients' lungs has produced encouraging results in a major UK trial.
Airway valve treatment improves lung function
A study has found that using airway valves to treat people with emphysema can improve lung function and exercise capacity.
New service opens for adult patients with developmental lung abnormalities
Dr Matthew Hind has started a new service at the Brompton Hospital to focus on adult patients with developmental lung abnormalities
Feature
A good year for the snot doctors
The chance to celebrate their research at last year's Imperial Festival has led to a year of amazing opportunities for two lung researchers.
Idiopathic pulmonary fibrosis cases linked with asbestos exposure
Some cases of the lung disease idiopathic pulmonary fibrosis (IPF) may be linked with asbestos exposure, according to the results of a new study.
2
